Glioblastoma, the most aggressive primary brain tumor, thrives in a microenvironment of relative immunosuppression within the relatively immune-privileged central nervous system. Despite treatments with surgery, radiation therapy, and chemotherapy, prognosis remains poor. The recent success of immunotherapy in the treatment of other cancers has renewed interest in vaccine therapy for the treatment of gliomas. In this article, we outline various immunotherapeutic strategies, review recent clinical trials data, and discuss the future of vaccine therapy for glioblastoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269657 | PMC |
| http://dx.doi.org/10.1097/PPO.0b013e3182431a73 | DOI Listing |
Publication Analysis
Top Keywords
immunotherapy treatment
8
vaccine therapy
8
treatment glioblastoma
4
glioblastoma glioblastoma
4
glioblastoma aggressive
4
aggressive primary
4
primary brain
4
brain tumor
4
tumor thrives
4
thrives microenvironment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!